The implantable medical devices market is set to grow from USD 126.3 billion in 2024 to USD 146.81 billion by 2031, with a CAGR of 6.8%. This growth is fueled by rising chronic disease prevalence and favorable reimbursement policies, particularly for pacemakers, with North America holding a 43% market share. Key innovations like 3D printing and wireless connectivity are transforming patient care, making these devices essential in modern healthcare.